{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:07:12Z","timestamp":1791022032211,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.atherosclerosis.2011.08.003","type":"journal-article","created":{"date-parts":[[2011,8,15]],"date-time":"2011-08-15T11:01:31Z","timestamp":1313406091000},"page":"778-783","source":"Crossref","is-referenced-by-count":12,"title":["Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy"],"prefix":"10.1016","volume":"219","author":[{"given":"Su Jin","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Oh","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Goo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-hyeon","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Bean","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Joon","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Su","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Myung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"New Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2009.06.011","article-title":"Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects","volume":"208","author":"Guaraldi","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0015","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Mller","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/QAD.0b013e328325a87c","article-title":"HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction","volume":"23","author":"Francisci","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0025","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/QAD.0b013e32832b514b","article-title":"Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis","volume":"23","author":"Hsue","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0030","first-page":"138","article-title":"Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging","volume":"70","author":"Vlassara","year":"1994","journal-title":"Lab Invest"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0035","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1016\/S0021-9258(18)99007-1","article-title":"Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo","volume":"266","author":"Dyer","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0040","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1042\/bj20021371","article-title":"Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury","volume":"370","author":"Yonekura","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0045","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.ATV.0000164804.05324.8b","article-title":"Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein?","volume":"25","author":"Hudson","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0050","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2174\/092986706777585013","article-title":"Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target","volume":"13","author":"Geroldi","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0055","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5414\/CNP61324","article-title":"Effect of advanced glycation end products on endotoxin-induced TNF-alpha, IL-1beta and IL-8 in human peripheral blood mononuclear cells","volume":"61","author":"Reznikov","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0065","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1016\/S0021-9258(17)36966-1","article-title":"Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors\/binding proteins","volume":"269","author":"Yan","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11883-000-0082-4","article-title":"Atherosclerosis and diabetes: the RAGE connection","volume":"2","author":"Schmidt","year":"2000","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0075","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts","volume":"4","author":"Park","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0080","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/01.CIR.0000039325.03698.36","article-title":"RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice","volume":"106","author":"Bucciarelli","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0085","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.ATV.0000160342.20342.00","article-title":"Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men","volume":"25","author":"Falcone","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0090","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.0000190660.32863.cd","article-title":"Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis","volume":"25","author":"Koyama","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0095","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1365-2362.2009.02212.x","article-title":"High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis","volume":"39","author":"Basta","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0105","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.CIR.74.6.1399","article-title":"Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging","volume":"74","author":"Pignoli","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0110","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.amjhyper.2006.05.010","article-title":"Evaluation of a new carotid intima-media thickness measurement by B-mode ultrasonography using an innovative measurement software, intimascope","volume":"19","author":"Yanase","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1751-7141.2008.00021.x","article-title":"Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: summary and discussion of the American Society of Echocardiography consensus statement","volume":"12","author":"Stein","year":"2009","journal-title":"Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199901073400103","article-title":"Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group","volume":"340","author":"O\u2019Leary","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2840-6-9","article-title":"Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes","volume":"6","author":"Humpert","year":"2007","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0130","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.metabol.2006.05.007","article-title":"Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects","volume":"55","author":"Yamagishi","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0135","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1002\/art.22217","article-title":"Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1","volume":"54","author":"Pullerits","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0140","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-Mller","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0145","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","article-title":"Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0150","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(05)63513-1","article-title":"Protease inhibitor-associated hyperglycaemia","volume":"350","author":"Dub","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0155","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0160","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.mcna.2009.02.008","article-title":"Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels","volume":"93","author":"Lakatta","year":"2009","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0165","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/01.ATV.0000183744.38509.de","article-title":"Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection","volume":"25","author":"Schillaci","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9343(96)00454-8","article-title":"Vascular abnormalities associated with long-term cigarette smoking identified by arterial waveform analysis","volume":"102","author":"McVeigh","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0175","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0895-7061(01)02326-3","article-title":"Clinical applications of arterial stiffness, task force. III. Recommendations for user procedures","volume":"15","author":"Van Bortel","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0180","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/COH.0b013e3281e38a98","article-title":"Atherosclerotic vascular disease in HIV: it is not just antiretroviral therapy that hurts the heart!","volume":"2","author":"van Leuven","year":"2007","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0185","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/QAD.0b013e328300581d","article-title":"Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men","volume":"22","author":"Kaplan","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0190","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.hjh.0000177535.45785.64","article-title":"Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension","volume":"23","author":"Geroldi","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0195","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.diabres.2005.12.013","article-title":"Development of an ELISA for esRAGE and its application to type 1 diabetic patients","volume":"73","author":"Sakurai","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0200","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.2337\/diacare.28.11.2716","article-title":"Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications","volume":"28","author":"Katakami","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2011.08.003_bib0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/CS20070353","article-title":"HIV-positive patients treated with protease inhibitors have vascular changes resembling those observed in atherosclerotic cardiovascular disease","volume":"115","author":"Lekakis","year":"2008","journal-title":"Clin Sci"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011007520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011007520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:41:59Z","timestamp":1638276119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011007520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0021915011007520"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.08.003","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}